The remit of the NREC-CTs is to review the submission of ethics applications related to Clinical Trials of Investigational Medicinal Products (CTIMP). This includes interventional studies and low-interventional studies involving medicinal products for human use.

Two NREC-CTs will run in parallel, NREC-CT A and NREC-CT B, with each committee meeting monthly.

The NREC-CTs will initially run concurrently with many local recognised RECs to review CTIMP ethics applications for a defined transition period. This approach will collectively support this important area of research and ensure a smooth transition ahead of the EU Clinical Trial Regulation.

The National Research Ethics Committee for Clinical Trials (NREC-CT) is recognised by the Department of Health under the S.I. No. 190/2004 - European Communities (Clinical Trials on Medicinal Products For Human Use) Regulations, 2004 and is authorised to carry out the ethics review of clinical trials of medicinal products.

The NREC-CT is fully compliant with the regulations as they relate to ethics committees, and endorses the conditions and principles of good clinical practice.

For further information related to the NREC-CT, please contact the National Office –

If you plan to submit a CTIMP application for ethics review, please visit Apply NREC-CT.

If you are interested in the underlying processes and management of the NREC-CT, please download our Operational Framework.

Details of all upcoming meetings, minutes and decisions are published here on our website. A full list of NREC-CT A and NREC-CT B members can also be viewed.

Scroll to Top
Skip to content